Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection?-Reference-Cited by-同舟云学术

Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection?

Published:2021-01-01 Issue:1 Volume:36 Page:1230-1235
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Deniz Secil¹,Uysal Tugba Kevser²,Capasso Clemente³^ORCID,Supuran Claudiu T.⁴^ORCID,Ozensoy Guler Ozen²^ORCID

Affiliation:

1. Department of Infectious Diseases, Faculty of Medicine, Pamukkale University, Denizli, Turkey

2. Department of Medical Biology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey

3. CNR-Institute of Biosciences and Bioresources, Napoli, Italy

4. NEUROFARBA Department, Section of Pharmaceutical and Nutriceutical Chemistry, Università degli Studi di Firenze, Laboratorio di Chimica Bioinorganica, Florence, Italy

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.1924165

Reference29 articles.

1. A deadly spillover: SARS-CoV-2 outbreak

2. Application of deep learning techniques for detection of COVID-19 cases using chest X-ray images: A comprehensive study

3. Angiotensin‐converting enzyme 2 ( ACE2 ), SARS‐CoV ‐2 and the pathophysiology of coronavirus disease 2019 ( COVID ‐19)

4. Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment Strategies;Current Microbiology;2024-05-11

2. SARS-CoV-2 Viral Replication Persists in the Human Lung for Several Weeks after Symptom Onset;American Journal of Respiratory and Critical Care Medicine;2024-04-01

3. Drug interactions of carbonic anhydrase inhibitors and activators;Expert Opinion on Drug Metabolism & Toxicology;2024-03-03

4. Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units;Talanta;2024-02

5. Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors;International Journal of Molecular Sciences;2024-01-12